therascreen FGFR RGQ RT-PCR Kit (CE IVD, not sold in the US) REF 874711

Class I - Dangerous

What Should You Do?

  1. Check if you have this product:
    Lot number: 172017804 Exp Date: 10.11.2022 169046610 Exp. Date: 12.06.2022
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Qiagen Sciences LLC
Reason for Recall:
Increased occurrence rate of false positive results, lead to a false positive sample result that could subsequently be incorrectly reported from the laboratory. A false positive result could lead to the risk of the patient being exposed to an inappropriate or suboptimal anti-cancer treatment and/or unnecessarily experiencing side effects
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
ongoing

Product Information

Full Description:

therascreen FGFR RGQ RT-PCR Kit (CE IVD, not sold in the US) REF 874711

Product Codes/Lot Numbers:

Lot number: 172017804 Exp Date: 10.11.2022 169046610 Exp. Date: 12.06.2022

Distribution:

Distributed in: IN, NC, MN, TX

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: Z-1651-2022

Related Recalls

Heater shaker module does not perform heating if the temperature is set below 40ΒΏC for static incubation steps when running IVD protocol QIAampΒΏ DSP DNA Mini Kit (cat. no. 61304), Protocol: Isolation of genomic DNA from Gram-positive bacteria (Script filename: Kt_name_Bacteria (Gram+) or rY'east_Enzymatic Lysis_ V2) which could potentially cause delayed or erroneous results depending on the downstream assay.

Jun 3, 2024 Diagnostic Equipment Nationwide View Details β†’